Innovation in radiopharmaceuticals for more accurate and effective diagnosis and treatment of cancer.

The ARC Hub for Advanced Manufacture of Targeted Radiopharmaceuticals, AMTAR, brings together researchers and industry who aim to make possible the reliable manufacture of radiopharmaceuticals at a scale to benefit all.

Established in 2023, AMTAR addresses shared industry challenges by developing new technologies and establishing a platform for design, manufacture and quality assurance of targeted radiopharmaceuticals.

AMTAR partners are a collaborative, complementary group from academic institutions and commercial enterprises, who provide broad expertise across the radiopharmaceutical supply chain.

The Hub is funded by the Australian Government through the Australian Research Council Industrial Transformation Research Program and our industry and university partners.